Edition:
India

FibroGen Inc (FGEN.OQ)

FGEN.OQ on NASDAQ Stock Exchange Global Select Market

38.38USD
30 Oct 2020
Change (% chg)

$-0.63 (-1.61%)
Prev Close
$39.01
Open
$38.54
Day's High
$38.85
Day's Low
$37.59
Volume
250,096
Avg. Vol
272,441
52-wk High
$51.00
52-wk Low
$22.65

Select another date:

Sat, Jul 11 2020

BRIEF-Fibrogen Says On July 8, Units And Astrazeneca Entered Into An Amendment To Amended And Restated License, Development And Commercialization Agreement

* FIBROGEN - ON JULY 8, UNITS AND ASTRAZENECA ENTERED INTO AN AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT

BRIEF-FibroGen Announces First Patient Enrolled In Pamrevlumab Clinical Trial For Acute Covid-19

* FIBROGEN ANNOUNCES FIRST PATIENT ENROLLED IN PAMREVLUMAB CLINICAL TRIAL IN PATIENTS HOSPITALIZED IN U.S. WITH ACUTE COVID-19

BRIEF-Fibrogen Announces New Roxadustat Data Presented At 2020 Era-Edta Virtual Congress

* FIBROGEN ANNOUNCES NEW ROXADUSTAT DATA PRESENTED AT 2020 ERA-EDTA VIRTUAL CONGRESS

BRIEF-Fibrogen Says First Patient Enrolled In COVID-19 Trial In Italy

* FIBROGEN ANNOUNCES FIRST PATIENT ENROLLED IN PAMREVLUMAB CLINICAL TRIAL IN PATIENTS HOSPITALIZED IN ITALY WITH SEVERE COVID-19 Source text for Eikon: Further company coverage:

Select another date: